Bayview Pharmacy is pleased to offer a compounded formulation of Hydrocortisone 0.5%/Clioquinol 2% Suppository, a solid dosage form that is inserted into a body cavity, typically the rectum or vagina. It dissolves or melts to release medication for local or systemic absorption. This suppository is specifically designed for the treatment of Anal Pruritus, Anal Fissures, Hemorrhoids, Proctitis, and Perianal Dermatitis.

The Hydrocortisone 0.5%/Clioquinol 2% Suppository is a combination of two active ingredients, Hydrocortisone and Clioquinol. Hydrocortisone is a corticosteroid that works to reduce inflammation and itching, while Clioquinol is an antifungal that aids in reducing the risk of infection. Together, these ingredients work synergistically to help heal the affected area and provide relief from symptoms such as itching, burning, and pain.

For patients, it is crucial to adhere to the instructions provided by your healthcare provider when using this suppository. Please note that this suppository should not be used for more than 7 consecutive days and should not be used in conjunction with other topical medications. Always consult with your healthcare provider for personalized advice.

For prescribers, the Hydrocortisone 0.5%/Clioquinol 2% Suppository is an effective treatment option for Anal Pruritus, Anal Fissures, Hemorrhoids, Proctitis, and Perianal Dermatitis. It is essential to consider the patient's medical history and any other medications they are currently taking before prescribing this suppository. This will ensure the best possible outcome for the patient.

If you have any questions about this formulation or how it can be used to treat these conditions, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your healthcare needs.

This Hydrocortisone 0.5%/Clioquinol 2% Suppository formulation is a compounded medication specifically designed for the treatment of various anal and rectal conditions such as Anal Pruritus, Anal Fissures, Hemorrhoids, Proctitis, and Perianal Dermatitis. The medication is a solid dosage form that is inserted into the rectum, where it dissolves or melts to release the active ingredients for local absorption.

Hydrocortisone, a corticosteroid, is included in the formulation for its anti-inflammatory and anti-itching properties. It works by reducing the body's immune response to these conditions, thereby alleviating associated symptoms such as swelling, redness, and itching. On the other hand, Clioquinol is an antifungal and antibacterial agent that helps to combat any potential or existing infections in the affected area. This combination of medications works synergistically to provide relief from the uncomfortable symptoms of these conditions, including itching, burning, and pain.

It is crucial for patients to understand that this formulation should not be used for more than 7 consecutive days. Prolonged use may lead to skin thinning and other adverse effects. Additionally, some patients may experience temporary burning or stinging upon application of the suppository. If any of these side effects occur, or if symptoms persist or worsen, patients should immediately contact their healthcare provider for further advice and treatment options.

As with any medication, it is important to use this formulation exactly as directed by a healthcare professional. Patients should also inform their healthcare provider of all other medications they are currently taking, including over-the-counter drugs, vitamins, and herbal supplements, to avoid potential drug interactions. If you have any questions or concerns about this formulation or its use, please consult with your healthcare provider.

This Hydrocortisone 0.5%/Clioquinol 2% Suppository formulation is designed to treat a range of conditions such as Anal Pruritus, Anal Fissures, Hemorrhoids, Proctitis, and Perianal Dermatitis. The suppository is inserted into the rectum where it is absorbed through the mucous membranes. The hydrocortisone component works to alleviate inflammation and itching, while the clioquinol component is effective in inhibiting the growth of bacteria and fungi. This combination of medications is designed to alleviate the symptoms associated with these conditions.

Patients are advised to use the suppository as directed by their healthcare provider. The suppository should be inserted into the rectum and left in place for a minimum of 15 minutes before removal. It is recommended that the suppository is not used more than once a day and not for more than 7 consecutive days. Patients who are pregnant or breastfeeding should avoid using this suppository.

Healthcare providers should closely monitor patients for any signs of adverse reactions, such as skin irritation, burning, or itching. If any of these symptoms occur, patients are advised to discontinue use of the suppository and immediately contact their healthcare provider. Healthcare providers should also be vigilant for any signs of infection in patients, such as fever, chills, or increased pain.

If you have any questions about this formulation or its usage, please do not hesitate to reach out for further information.

This Hydrocortisone 0.5%/Clioquinol 2% Suppository formulation is a solid dosage form designed for insertion into a body cavity, typically the rectum or vagina. Once inserted, it dissolves or melts to release the medication for local or systemic absorption. It is primarily used to treat a variety of conditions such as anal itching, anal abscesses, and anal fistulas. Additionally, it can be utilized to alleviate inflammation and pain associated with anal fissures, hemorrhoids, proctitis, and perianal dermatitis.

It is important to note that this formulation should not be used to treat any other conditions not specifically listed. Potential side effects may include burning, itching, or irritation at the site of application. Patients should be aware that this formulation should not be used for more than 7 days without consulting a healthcare provider. If any questions or concerns arise regarding the use of this formulation, patients are encouraged to reach out to their healthcare provider or pharmacist for further guidance and information.